Ashley M. Brinkman

Statistics

Publications

Citations

295

H-Index

Active since

2012

Affiliations

Collaborations Pharmaceuticals (United States)(Current)

SC Johnson (United States)

University of Wisconsin–Madison

University of Wisconsin Carbone Cancer Center

Ashley M. Brinkman is an author at Collaborations Pharmaceuticals (United States) specializing in life sciences, hormone receptors, and estrogen receptor signaling.

ORCID

Publications per year

2012–2020

Publications

Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer

Ashley M. Brinkman, Guojun Chen, Yidan Wang et al. · Biomaterials · 2016 · 99 citations · Full text

Pharmacy, Molecular Pharmaceutics, Oncology +15

Identification of Estrogen Receptor Dimer Selective Ligands Reveals Growth-Inhibitory Effects on Cells That Co-Express ERα and ERβ

Emily Powell, Erin K. Shanle, Ashley M. Brinkman et al. · PLoS ONE · 2012 · 68 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +14

Machine Learning Models for Estrogen Receptor Bioactivity and Endocrine Disruption Prediction

Kimberley M. Zorn, Daniel H. Foil, Thomas R. Lane et al. · Environmental Science & Technology · 2020 · 51 citations · Full text

Life Sciences, Environmental Sciences, Toxicology +16

Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells

Ashley M. Brinkman, Jiacai Wu, Karen Ersland et al. · BMC Cancer · 2014 · 34 citations · Full text

Medicine, Oncology, Pharmacology +10

Comparison of Machine Learning Models for the Androgen Receptor

Kimberley M. Zorn, Daniel H. Foil, Thomas R. Lane et al. · Environmental Science & Technology · 2020 · 32 citations · Full text

Life Sciences, Endocrinology, Toxicology +14

1–5 of 6